Testicular Tumor Cells
Testicular cancers, primarily arising from germ cells, represent a distinct group of malignancies that are often highly treatable but can present complex biological and clinical challenges. Our Testicular Tumor Cells collection provides a specialized set of models to investigate the pathogenesis, stemness properties, and therapeutic response of embryonal carcinomas and other germ cell tumors.
This portfolio includes well-characterized lines like the pluripotent NT2-D1, patient-derived embryonal carcinoma models (NEC15, NEC14, 833KE), and the unique NCR-G series representing complex type germ cell tumors. These models are essential tools for studying developmental pathways, epigenetic regulation, and mechanisms of chemotherapy sensitivity and resistance.
Germ Cell Origin Embryonal Carcinoma Focus Pluripotent Models Validated
Key Features & Expertise
Our testicular tumor cell lines are characterized to support research in germ cell tumor biology
Focused on Germ Cell & Embryonal Carcinoma Models
- Core models of embryonal carcinoma, the stem cell component of mixed germ cell tumors
- Includes the pluripotent NT2-D1 line, capable of differentiation into multiple lineages
- Features patient-derived models (NEC series, 833KE) and complex type germ cell tumors (NCR-G series)
Characterized for Pluripotency & Developmental Pathways
- Profiled for expression of pluripotency markers (OCT4, NANOG, SOX2)
- Suitable for studying differentiation, epigenetic regulation, and developmental signaling
- Models with documented sensitivity to cisplatin, a cornerstone of testicular cancer therapy
Quality-Controlled for Reliable Research
- STR-authenticated to confirm genetic identity and germ cell origin
- Includes mycoplasma-eliminated derivatives (e.g., NEC8) for critical studies
- Supplied with detailed characterization data and culture protocols
FAQ
What is the difference between embryonal carcinoma cell lines (like NEC15, NT2-D1) and the NCR-G series?
Embryonal carcinoma (EC) lines like NEC15 and NT2-D1 represent a pure histology of the stem cell component found in many mixed germ cell tumors. They are pluripotent and used to study stemness and differentiation. The NCR-G series are described as "complex type germ cell tumors," which may better model the heterogeneity and mixed cellular composition seen in some patient tumors, potentially containing multiple lineages.
Why is NT2-D1 a particularly important model for testicular cancer research?
NT2-D1 is a pluripotent human embryonal carcinoma cell line. It is one of the most well-characterized models of its kind and is widely used not only in testicular cancer research but also as a model for studying human embryonic development, differentiation (notably into neurons), and epigenetic regulation, due to its robust expression of core pluripotency factors.
Can these cell lines be used to study cisplatin resistance, a major clinical challenge?
While testicular cancers are generally cisplatin-sensitive, studying de novo or acquired resistance is crucial. Many of these embryonal carcinoma models are intrinsically sensitive to cisplatin, making them excellent tools for establishing resistant sublines. Comparing sensitive parent lines (like 833KE) to derived resistant variants can reveal key resistance mechanisms.
Are these cell lines suitable for differentiation studies?
Yes, absolutely. Embryonal carcinoma lines, especially NT2-D1, are classic models for studying differentiation. They can be induced to differentiate into various cell types (e.g., neuronal lineage) using agents like retinoic acid. This makes them valuable for researching the developmental biology of germ cell tumors and the effects of differentiation therapy.
How are these germ cell tumor lines authenticated?
All cell lines are STR (Short Tandem Repeat) profiled to confirm their unique genetic identity. This is essential to verify they are indeed of human testicular/germ cell origin and not a misidentified cell line, ensuring the validity of research findings in this specialized field.
What are the typical culture conditions for embryonal carcinoma cell lines?
Most embryonal carcinoma lines, including NT2-D1 and the NEC series, are cultured in DMEM or RPMI-1640 supplemented with 10% FBS. They are adherent cells. It's important to maintain them in an undifferentiated state by passaging before confluence; using low passage numbers is often recommended for stemness studies.